$5.25 (3.55%)

Volume: 1.454M

Closed: Jun 02, 2023

Hollow Logo Score: -3.508
Fate Therapeutics Stock
$5.25 (3.55%)

Volume: 1.454M

Closed: Jun 02, 2023

Score Hollow Logo -3.508
NASDAQ:FATE

Fate Therapeutics Stock Price (Quote)

$5.25 ( 3.55% ) Friday, 2nd Jun 2023

Range Low Price High Price Comment
30 days $4.74 $6.60 Friday, 2nd Jun 2023 FATE stock ended at $5.25. This is 3.55% more than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 4.35% from a day low at $5.06 to a day high of $5.28.
90 days $4.74 $6.74
52 weeks $4.02 $37.13

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2023-06-02 $5.18 $5.28 $5.06 $5.25 1 454 288
2023-06-01 $5.05 $5.20 $4.80 $5.07 1 651 776
2023-05-31 $4.96 $5.26 $4.90 $5.05 2 027 216
2023-05-30 $5.16 $5.30 $4.88 $4.96 2 386 915
2023-05-26 $5.14 $5.19 $5.00 $5.13 1 609 074
2023-05-25 $5.34 $5.34 $4.99 $5.04 2 260 121
2023-05-24 $5.46 $5.46 $5.25 $5.34 1 603 749
2023-05-23 $5.26 $5.65 $5.26 $5.47 1 862 822
2023-05-22 $4.97 $5.33 $4.95 $5.23 2 253 099
2023-05-19 $4.98 $5.11 $4.91 $4.98 1 512 955
2023-05-18 $5.07 $4.99 $4.74 $4.89 1 901 002
2023-05-17 $5.02 $5.10 $4.82 $5.03 1 693 667
2023-05-16 $5.17 $5.18 $4.89 $4.91 1 934 197
2023-05-15 $5.00 $5.40 $4.99 $5.33 2 294 958
2023-05-12 $5.28 $5.28 $4.90 $4.97 2 018 546
2023-05-11 $5.34 $5.40 $5.17 $5.26 1 938 258
2023-05-10 $5.50 $5.61 $5.25 $5.34 2 182 745
2023-05-09 $5.37 $5.59 $5.29 $5.39 2 049 009
2023-05-08 $5.65 $5.67 $5.25 $5.45 2 828 272
2023-05-05 $6.28 $6.28 $5.51 $5.68 3 069 505
2023-05-04 $6.00 $6.60 $5.58 $6.17 3 326 802
2023-05-03 $5.88 $6.48 $5.86 $6.32 2 930 044
2023-05-02 $6.32 $6.32 $5.72 $5.92 3 595 616
2023-05-01 $6.10 $6.47 $6.08 $6.36 2 529 747
2023-04-28 $5.86 $6.11 $5.72 $6.07 2 080 988
2023-04-27 $5.88 $6.03 $5.71 $5.84 1 933 752
2023-04-26 $6.03 $6.12 $5.78 $5.82 1 597 198
2023-04-25 $6.25 $6.46 $5.97 $6.03 2 033 308
2023-04-24 $6.36 $6.40 $6.12 $6.34 1 410 516
2023-04-21 $6.03 $6.23 $5.99 $6.22 2 066 141
2023-04-20 $6.34 $6.35 $5.96 $6.00 2 095 534
2023-04-19 $6.23 $6.52 $6.14 $6.36 1 414 340
2023-04-18 $6.73 $6.74 $6.16 $6.23 2 601 123
2023-04-17 $6.08 $6.66 $6.07 $6.59 2 763 934
2023-04-14 $5.84 $6.22 $5.80 $6.01 10 498 333
2023-04-13 $5.76 $6.29 $5.64 $6.20 3 671 343
2023-04-12 $5.62 $5.90 $5.56 $5.61 2 236 187
2023-04-11 $5.52 $5.71 $5.47 $5.64 1 570 936
2023-04-10 $5.81 $5.81 $5.45 $5.48 2 361 929
2023-04-06 $5.52 $5.89 $5.44 $5.85 2 118 153
2023-04-05 $5.50 $5.65 $5.46 $5.50 1 137 559
2023-04-04 $5.72 $5.89 $5.44 $5.53 1 799 429
2023-04-03 $5.59 $5.89 $5.56 $5.81 1 763 415
2023-03-31 $5.38 $5.73 $5.29 $5.70 1 814 027
2023-03-30 $5.61 $5.66 $5.28 $5.30 1 721 720
2023-03-29 $5.35 $5.58 $5.25 $5.55 2 049 203
2023-03-28 $5.45 $5.47 $5.26 $5.27 1 693 367
2023-03-27 $5.37 $5.62 $5.34 $5.48 2 123 649
2023-03-24 $5.19 $5.43 $5.05 $5.39 1 708 975
2023-03-23 $5.33 $5.36 $5.08 $5.23 2 140 273
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT